Peter T. Silberstein, MD

Article

Influence of Patient Demographics and Facility Type on Overall Survival in Sezary Syndrome

Author:: Peter T. Silberstein, MD

Publish date: September 10, 2024

Article

Surgical Management of SDH-Deficient Gastrointestinal Stromal Tumors (GIST): A National Cancer Database Review

Author:: Peter T. Silberstein, MD

Publish date: September 6, 2024

Article

Factors Affecting Academic Center Access in Merkel Cell Carcinoma: An NCDB Analysis

Author:: Peter T. Silberstein, MD

Publish date: September 6, 2024

Article

Impact of Facility Type on Survival Outcomes in Pancreatic Neuroendocrine Carcinoma: An Analysis of the National Cancer Database

Author:: Peter T. Silberstein, MD

Publish date: September 6, 2024

Article

An NCDB Analysis of Factors Associated With the Receipt of Surgery in Myxoid/Round Cell Liposarcoma

Author:: Peter T. Silberstein, MD

Publish date: September 6, 2024

Article

Clear Cell Sarcoma Incidence and Survival: A SEER Database Analysis

Author:: Peter T. Silberstein, MD

Publish date: September 6, 2024

Article

Survival and Incidence of Gastric Neuroendocrine Tumors: A SEER Database Analysis

Author:: Peter T. Silberstein, MD

Publish date: September 6, 2024

Article

Multimodal Treatment Approaches for Basaloid Squamous Cell Carcinoma of the Larynx

Author:: Peter T. Silberstein, MD

Publish date: August 30, 2024

Article

Presentation of a Rare Malignancy: Leiomyosarcoma of the Prostate (FULL)

Author:: Peter T. Silberstein, MD

Publish date: February 3, 2020

Prostatic leiomyosarcoma is an aggressive malignancy with a high risk of metastasis and a poor prognosis that poses unique diagnostic and treatment...

Article

Treatment Facility: An Important Prognostic Factor for Dedifferentiated Liposarcoma Survival (FULL)

Author:: Peter T. Silberstein, MD

Publish date: August 8, 2019

A National Cancer Database study of on survival outcomes for patients with dedifferentiated
liposarcomas found that insurance status, median hou...

Article

Systemic Therapy in Metastatic Melanoma

Author:: Peter T. Silberstein, MD

Publish date: March 31, 2017

New targeted treatments and therapies for metastatic melanoma are improving patient prognosis and survival.

Article

New Treatment Options for Metastatic Thyroid Cancer

Author:: Peter T. Silberstein, MD

Publish date: September 2, 2015

Newer multitargeted kinase inhibitors show prolonged overall and progression-free survival in patients with metastatic differentiated and medullary...

Article

Colorectal Carcinoma and Emerging Targeted Therapies

Author:: Peter T. Silberstein, MD

Publish date: September 2, 2015

Targeted therapies for specific mutations in colorectal cancer have led to an increase in patient overall survival.